Advisory: Alert on Biophytis H1 operating loss withdrawn
Sept 20 (Reuters) - The alert on Biophytis half-year
operating loss was sent in error from an old template and has
been withdrawn.
There will be no replacement alert. The company did not
publish any financial details at that time.
STORY_NUMBER: FWN3AW01T
STORY_DATE: 20/09/2023
STORY_TIME: 10:16:56
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 7696600))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon